| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27.7M | — | +5622.3% |
| Cost of Revenue | $22.6M | — | — |
| Gross Profit | $5.1M | — | +1436.1% |
| R&D Expense | $1.2M | — | -30.2% |
| SG&A Expense | $11.7M | — | +59.2% |
| Operating Income | -$10.4M | — | +0.1% |
| Interest Expense | $200K | — | +0.0% |
| Pre-tax Income | -$31.7M | — | -146.3% |
| Income Tax | -$15K | — | +0.0% |
| Net Income | -$35.3M | — | -174.0% |
| EPS (Basic) | -$1.00 | — | +73.7% |
| EPS (Diluted) | -$1.00 | — | +73.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $15.2M | -9.1% | +89.6% |
| Accounts Receivable | $9.1M | -25.2% | +1479.6% |
| Inventory | $19.4M | +26.1% | +737.5% |
| Current Assets | $50.3M | -2.9% | +301.8% |
| Total Assets | $78.3M | -3.6% | +188.8% |
| Current Liabilities | $91.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.5M | — | +31.4% |
| Capital Expenditures | $131K | — | +191.1% |
| Investing Cash Flow | -$825K | — | -1733.3% |
| Financing Cash Flow | $9.5M | — | -50.4% |
| Free Cash Flow | -$10.6M | — | +30.8% |
| +626.7% |
| Long-term Debt | $10.6M | +2248.7% | — |
| Total Liabilities | $92.0M | +81.0% | +619.3% |
| Stockholders' Equity | -$26.6M | -250.0% | -291.0% |